Evidence map›Paper›PMID 41291609›Full record

ArticleBMC public health2025

The association between polypharmacy and quality of life in elderly population in Southern Iran: Bushehr Elderly Health (BEH) Program.

Yasaman Zarinfar, Nekoo Panahi, Razieh Shojaei, Marjan Hosseinpour, Iraj Nabipour, Bagher Larijani, Noushin Fahimfar, Afshin Ostovar

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yasaman Zarinfar *Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Nekoo Panahi *Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. nekoo.panahi@gmail.com.ORCID http://orcid.org/0000-0003-2184-7043
Razieh ShojaeiMetabolic Disorders Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Marjan HosseinpourOsteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Iraj NabipourThe Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran.
Bagher LarijaniEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Noushin FahimfarOsteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Afshin OstovarOsteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPolypharmacy is common among the elderly and may negatively impact quality of life (QoL). This study aims to investigate the association between polypharmacy and physical and mental components of QoL among older adults, with separate analyses by gender, in a Southern Iranian population.

methodsIn this cross-sectional study, individuals aged over 60 years from the Bushehr Elderly Health Program were categorized by medication use: polypharmacy (≥ 5 medications) versus no polypharmacy (< 5 medications). QoL was measured using the 12-Item Short Form Survey (SF-12). Multivariable linear regression evaluated the association between polypharmacy and physical and mental QoL components, adjusting for age, body mass index, physical activity, and mental and physical comorbidities.

resultsAmong 2,399 participants (52% women), polypharmacy prevalence was 33.3% in women and 20.8% in men. Those with polypharmacy had significantly lower QoL scores. The largest mean differences were in mental health (MD: 3.22; 95% CI: 1.56–4.87; p = 0.001) and bodily pain (MD: 3.16; 1.70–4.62; p < 0.001) for women, and general health (MD: 3.78; 2.32–5.23; p < 0.001) and vitality (MD: 2.30; 0.84–3.76; p = 0.002) for men. Polypharmacy was significantly associated with lower Physical Component Summary (PCS) scores (men: β= -1.76, 95% CI: -2.79 to -0.73, p = 0.001; women: β= -1.98, -3.02 to -0.95, p < 0.001) and Mental Component Summary (MCS) scores (men: β= -1.74, -2.86 to -0.63, p = 0.002; women: β= -2.28, -3.56 to -1.01, p < 0.001). After adjustment, the association with MCS scores remained significant (men: β= -1.64, -2.72 to -0.55, p < 0.001; women: β= -1.80, -3.00 to -0.61, p = 0.009), whereas PCS associations attenuated and became nonsignificant (men: β = -0.68, -1.67 to 0.30, p = 0.17; women: β = -0.83, -1.77 to 0.11, p = 0.08).

conclusionPolypharmacy is prevalent among Southern elderly Iranians and is linked to reduced QoL, especially mental health, in both sexes. These findings highlight the need for careful medication management and prescription review in older adults. Limitations include the cross-sectional design that restricts causal interpretations and potential residual confounding. Future longitudinal studies should investigate causality and interventions to minimize polypharmacy and improve QoL in this population.

Indexed as

PolypharmacyQuality of LifeAgedAged, 80 and overCross-Sectional StudiesFemaleHumansIranMaleMiddle AgedMentalOldPhysicalPolypharmacyQuality of life

Identifiers

PMID41291609
PMCPMC12648909

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.